SEC Form 4 · accession 0001209191-15-081690
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Blight
Officer — Chief Scientific Officer
Period of report
Nov 20, 2015
Accepted (ET)
Nov 23, 2015 · 8:01 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 20, 2015 | M | 500 | $8.50 | A | 72,159 | D | |
| Common StockF1 | Nov 20, 2015 | S | 500 | $37.47 | D | 71,659 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $8.50 | Nov 20, 2015 | M | 500 | D | — | Sep 25, 2016 | Common Stock | 500 | 0 | D |
Explanation of responses
- F1Exercises and sales pursuant to a 10b5-1 Plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- F2The shares subject to these options vested in installments and were fully vested on 9/25/2010.